Idioma:

Stem-Cell Transplantation for Myelofibrosis

Deeg, H. Joachim ; Appelbaum, Frederick R

The New England journal of medicine, 2001-03, Vol.344 (10), p.775-776 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
Stem-Cell Transplantation for Myelofibrosis
Autor: Deeg, H. Joachim ; Appelbaum, Frederick R
Assuntos: Adolescent ; Adult ; Age Factors ; Aged ; Care and treatment ; Child ; Disease-Free Survival ; Hematopoietic Stem Cell Transplantation ; Humans ; Middle Aged ; Myelofibrosis ; Primary Myelofibrosis - mortality ; Primary Myelofibrosis - therapy ; Stem cells ; Survival Rate ; Transplantation
É parte de: The New England journal of medicine, 2001-03, Vol.344 (10), p.775-776
Notas: SourceType-Other Sources-1
ObjectType-Commentary-2
ObjectType-Correspondence-1
Descrição: To the Editor: In response to Tefferi's excellent review of myelofibrosis (April 27 issue), 1 Guardiola and colleagues have provided the results of allogeneic stem-cell transplantation in their patients with myelofibrosis (Aug. 31 issue). 2 The authors refer to a previous report, 3 which included data on 55 patients who underwent transplantation at a number of institutions, including the Fred Hutchinson Cancer Research Center; they then provide information on 11 new patients (with no indication as to where those patients underwent transplantation) and present a brief analysis of the results in all 66 patients. These results show an estimated five-year overall survival rate . . .
Editor: United States: Massachusetts Medical Society
Idioma: Inglês

Links

Voltar para lista de resultados